You just read:

Nordic Nanovector Completes Patient Enrolment Into Phase 1 Trial of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL)

News provided by

Nordic Nanovector

Jul 11, 2019, 08:55 ET